The KDIGO workgroup recommended CKD-MBD, which encompasses systemic disorders of mineral and bone metabolism due to CKD, including altered levels of Ca, P, and PTH; disturbed bone modeling; and calcification in arteries and soft tissues [28]. This evidence concerns the gene PTH and Marchiafava-Bignami disease.